For Investors
₹3 Cr for 5%. Patent-shielded. Government-rails native.
₹60 Cr pre-seed valuation.
BBB owns the only issued Indian patent for the hardware dispensing layer (No. 202621008558). KEM Hospital is the anchor pilot. NHA pays ₹5/Rx via DSC registry — recurring, regulated, and ours by default. Read the 7-year roadmap from Mumbai to pan-India.
₹3 Cr
Pre-seed ask
5% equity · ₹60 Cr valuation
7
Year roadmap
KEM → pan-India
₹22–27 L
NHA per hospital/yr
Automated via DSC
IP shield
Patent No. 202621008558 — no comparable product can ship without infringement.
Anchor pilot
KEM Hospital, Mumbai — 1,800 beds. BOOT deal locks 5-year revenue per hospital.
Layered revenue
₹10L set-up + ₹83k/mo ADM + ₹20k/15 beds WVM + ₹50k/mo SaaS + ₹5/Rx NHA DSC = ₹22–27 L/yr/hospital from govt alone.
TAM = 25,000+
Every government pharmacy in India is addressable via UHI on Day 1. No new infra needed.
Founded by pharma + IIT Bombay engineering + MBA Finance